Of 52 patients surveyed in North Philadelphia, 98% had heard of the drugs, yet only 35% knew about possible long-term health problems and some expected losses past 75 pounds in a year.
Recap by typeshit. Full story at BIOENGINEER.
U of T researchers built the AI tool with the aim of speeding up how new peptide drugs are found. The university's announcement has the details.
Fractyl plans to file a De Novo request with the FDA in late Q4, yet its shares closed about 63% lower that day over a class action and doubts about 12-month results.
Health records from 131 million adults linked GLP-1s to fewer dialysis or transplant cases. The researchers stress the study is observational and can't prove cause.
Centre Daily Times looks at how peptides taken by mouth can get past the gut intact and reach specific spots in the body, a key hurdle for pill versions of these drugs.
Fiber, protein, berberine and curcumin get a look, though experts quoted say none come close to the effect of prescription GLP-1 drugs.
Analysts expect a launch around 100,000 won a month, about half of Wegovy's starting price. Its 9.02% average weight loss over 40 weeks trails Mounjaro and Wegovy.
Loading…